Boston Scientific Corp (BSX)
72.72
-0.72
(-0.97%)
USD |
NYSE |
May 08, 16:00
72.57
-0.14
(-0.20%)
After-Hours: 20:00
Boston Scientific Enterprise Value: 116.48B for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 116.48B |
| May 06, 2024 | 115.19B |
| May 03, 2024 | 115.63B |
| May 02, 2024 | 114.43B |
| May 01, 2024 | 114.69B |
| April 30, 2024 | 114.19B |
| April 29, 2024 | 115.12B |
| April 26, 2024 | 116.09B |
| April 25, 2024 | 116.22B |
| April 24, 2024 | 115.71B |
| April 23, 2024 | 109.94B |
| April 22, 2024 | 108.52B |
| April 19, 2024 | 107.50B |
| April 18, 2024 | 107.64B |
| April 17, 2024 | 108.43B |
| April 16, 2024 | 108.66B |
| April 15, 2024 | 107.67B |
| April 12, 2024 | 108.59B |
| April 11, 2024 | 109.72B |
| April 10, 2024 | 109.44B |
| April 09, 2024 | 109.46B |
| April 08, 2024 | 109.50B |
| April 05, 2024 | 109.31B |
| April 04, 2024 | 108.12B |
| April 03, 2024 | 108.68B |
| Date | Value |
|---|---|
| April 02, 2024 | 107.68B |
| April 01, 2024 | 108.64B |
| March 31, 2024 | 109.21B |
| March 28, 2024 | 109.15B |
| March 27, 2024 | 109.34B |
| March 26, 2024 | 108.34B |
| March 25, 2024 | 107.39B |
| March 22, 2024 | 107.87B |
| March 21, 2024 | 107.79B |
| March 20, 2024 | 107.61B |
| March 19, 2024 | 108.12B |
| March 18, 2024 | 107.32B |
| March 15, 2024 | 105.83B |
| March 14, 2024 | 106.76B |
| March 13, 2024 | 105.55B |
| March 12, 2024 | 107.68B |
| March 11, 2024 | 105.67B |
| March 08, 2024 | 107.93B |
| March 07, 2024 | 107.98B |
| March 06, 2024 | 107.39B |
| March 05, 2024 | 106.80B |
| March 04, 2024 | 107.41B |
| March 01, 2024 | 106.97B |
| February 29, 2024 | 105.62B |
| February 28, 2024 | 106.76B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
45.92B
Minimum
Mar 23 2020
116.48B
Maximum
May 07 2024
71.96B
Average
68.55B
Median
Aug 11 2021
Enterprise Value Benchmarks
| ResMed Inc | 32.52B |
| Stryker Corp | 136.99B |
| Align Technology Inc | 20.67B |
| Abbott Laboratories | 192.86B |
| Axonics Inc | 3.107B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 492.00M |
| Revenue (Quarterly) | 3.856B |
| Total Expenses (Quarterly) | 3.163B |
| EPS Diluted (Quarterly) | 0.33 |
| Gross Profit Margin (Quarterly) | 68.65% |
| Profit Margin (Quarterly) | 12.76% |
| Earnings Yield | 1.64% |
| Operating Earnings Yield | 2.36% |
| Normalized Earnings Yield | 1.765 |